Trial Profile
Prospective, controlled, randomized trial investigating changes in levels of various cytokines post intravitreal injection by triamcinolone or bevacizumab in treatment of branch retinal vein occlusion (BRVO)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone (Primary)
- Indications Retinal vein occlusion
- Focus Pharmacodynamics
- 06 Nov 2015 New trial record